KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Return on Assets (2018 - 2025)

Aquestive Therapeutics has reported Return on Assets over the past 8 years, most recently at 0.52% for Q4 2025.

  • Quarterly results put Return on Assets at 0.52% for Q4 2025, down 10.0% from a year ago — trailing twelve months through Dec 2025 was 0.52% (down 10.0% YoY), and the annual figure for FY2025 was 0.64%, down 8.0%.
  • Return on Assets for Q4 2025 was 0.52% at Aquestive Therapeutics, up from 0.54% in the prior quarter.
  • Over the last five years, Return on Assets for AQST hit a ceiling of 0.13% in Q4 2023 and a floor of 1.31% in Q3 2022.
  • Median Return on Assets over the past 5 years was 0.55% (2023), compared with a mean of 0.67%.
  • Biggest five-year swings in Return on Assets: surged 110bps in 2023 and later plummeted -46bps in 2025.
  • Aquestive Therapeutics' Return on Assets stood at 1.11% in 2021, then rose by 10bps to 1.0% in 2022, then soared by 87bps to 0.13% in 2023, then tumbled by -210bps to 0.42% in 2024, then dropped by -24bps to 0.52% in 2025.
  • The last three reported values for Return on Assets were 0.52% (Q4 2025), 0.54% (Q3 2025), and 0.66% (Q2 2025) per Business Quant data.